Jacob sits down with Dr. Amy Abernethy, whose health tech career spans from clinician and researcher to CMO at Flatiron Health to Principal Deputy Commissioner and Chief Innovation Officer at the FDA to CMO and President of Product Development at Verily to co-founder of her own non-profit to accelerate evidence generation. They discuss the current and future states of real-world evidence, how clinical research can improve, the adoption of GenAI in healthcare, Verily’s growth story, her new venture, and more. (0:00) intro(0:40) real-world evidence(13:48) the future of control arms in clinical trials(22:16) startup ideas(25:04) generative AI in healthcare(27:18) regulating AI(35:09) the evolution of Verily(38:26) what is next for Amy?(42:59) over-hyped/under-hyped(43:37) one policy change to improve healthcare in the U.S. Out-Of-Pocket: https://www.outofpocket.health/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related